Amino Health, a digital healthcare guidance company, closed $80 million in both equity and debt financing led by Transformation Capital and Oxford Finance, respectively. In the face of declining digital health investment, this funding enables the company to scale its technology and continue its growth trajectory.
“While healthcare has evolved significantly over the last 10 years, Amino Health has remained steadfast in our commitment to the needs of patients by empowering them with the information necessary to make informed healthcare decisions,” David Vivero, CEO and co-founder of Amino Health, said. “This investment and financing validates our core belief that putting people first has value in healthcare, and the need for pioneering technology solutions that support this endeavor is not only important – it’s imperative. In a crowded, highly regulated market, this funding will fuel Amino’s continued growth, product innovation and ability to facilitate deep integrations with enterprise partners to support more patients at scale.”
“Amino Health has the right combination of an experienced and values-driven leadership team, a technology stack designed for substantial scale and a partner-driven go-to market solution,” Mike Dixon, managing partner at Transformation Capital, said. “With their advanced data insights to personalized care recommendations for consumers, Amino Health is unlike any other player in the market. We’re excited to be part of their continued growth.”
Transformation Capital joined previous Amino Health investors, including North Woodmere Capital, Commerce Ventures, Red Swan Ventures and WTI.
“For the past 20 years, we’ve partnered with innovative companies aiming to reduce costs and improve outcomes in healthcare,” Rohit Gandhi, senior director of healthcare services at Oxford Finance, said. “Amino Health aligns with this vision, making it an ideal company to add to our portfolio. We’re looking forward to supporting them in their ongoing success.”
